Phio Pharmaceuticals Corp. (PHIO) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Phio Pharmaceuticals Corp. (PHIO) quarterly balance sheet — complete assets, liabilities & equity history

Quarterly statement

PHIO Balance Sheet

Phio Pharmaceuticals Corp. (PHIO) balance sheet — 15-year assets, liabilities & shareholders' equity history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Total Current Assets	11.31M	14.3M	17.4M	21.48M	11.49M	11.29M	13.44M	5.74M	5.86M	5.29M	6.85M	9.32M	9.33M	12.04M	9.4M	12.45M	15.38M	19.69M	21.67M	24.73M
Cash & Short-Term Investments	10.61M	13M	17.03M	21.03M	10.71M	10.78M	13.28M	5.38M	5.39M	4.7M	6.47M	8.49M	8.41M	11.31M	9.04M	11.78M	14.48M	18.02M	20.46M	24.06M
Cash Only	10.61M	13M	17.03M	21.03M	10.71M	10.78M	13.28M	5.38M	5.39M	4.7M	6.47M	8.49M	8.41M	11.31M	9.04M	11.78M	14.48M	18.02M	20.46M	24.06M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Days Sales Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	701K	1.3M	371K	445K	788K	519K	158K	354K	474K	594K	373K	832K	50K	50K	50K	50K	50K	50K	50K	50K
Total Non-Current Assets	7K	9K	10K	11K	12K	7K	4K	2K	1K	4K	5K	42K	211K	261K	303K	368K	414K	456K	495K	443K
Property, Plant & Equipment	7K	9K	10K	11K	12K	7K	4K	2K	1K	1K	2K	39K	208K	255K	297K	344K	390K	429K	468K	416K
Fixed Asset Turnover	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	0	0	0	0	0	0	0	3K	3K	3K	3K	6K	6K	24K	24K	27K	27K	27K
Total Assets	11.32M	14.31M	17.41M	21.49M	11.51M	11.3M	13.44M	5.74M	5.87M	5.3M	6.85M	9.36M	9.54M	12.3M	9.71M	12.81M	15.79M	20.14M	22.16M	25.17M
Asset Turnover	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Asset Growth %	-1.63%	26.6%	29.55%	274.47%	96.16%	113.39%	96.12%	-38.72%	-38.52%	-56.93%	-29.4%	-26.92%	-39.59%	-38.96%	-56.2%	-49.09%	-43.49%	-36.37%	-34.54%	59.92%
Total Current Liabilities	886K	901K	260K	435K	516K	1.21M	1.27M	1.01M	919K	1.52M	1.25M	1.63M	2.33M	2.39M	2.4M	1.94M	2.19M	3.04M	2.57M	3.07M
Accounts Payable	886K	901K	260K	435K	516K	235K	427K	253K	184K	335K	320K	657K	173K	641K	902K	779K	543K	1.15M	329K	283K
Days Payables Outstanding	-	52.83K	31.27K	29.62	29.25	28.05	2.04K	20.41	37.07	34.41	38.72	887.91	20.71	1.43K	35.45	37.68	31.02	51.54	17.36	12.51
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	886K	0	0	-360K	-732K	0	0	31K	0	0	0	720K	0	0	0	19K	0	0	0	0
Current Ratio	12.77x	15.87x	66.93x	49.37x	22.27x	9.36x	10.58x	5.65x	6.38x	3.47x	5.48x	5.71x	4.01x	5.03x	3.92x	6.42x	7.01x	6.48x	8.42x	8.06x
Quick Ratio	12.77x	15.87x	66.93x	49.37x	22.27x	9.36x	10.58x	5.65x	6.38x	3.47x	5.48x	5.71x	4.01x	5.03x	3.92x	6.42x	7.01x	6.48x	8.42x	8.06x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	1.81M	804K	690K	905K	1.15M	0	0	0	0	0	0	0	0	0	0	35K	70K	104K	138K	170K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	35K	70K	104K	138K	170K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	1.81M	804K	690K	905K	1.15M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Liabilities	2.7M	1.71M	950K	1.34M	1.67M	1.21M	1.27M	1.01M	919K	1.52M	1.25M	1.63M	2.33M	2.39M	2.4M	1.97M	2.26M	3.14M	2.71M	3.24M
Total Debt	0	0	0	0	0	0	0	0	0	0	0	35K	70K	104K	138K	170K	202K	234K	265K	295K
Net Debt	-10.61M	-13M	-17.03M	-21.03M	-10.71M	-10.78M	-13.28M	-5.38M	-5.39M	-4.7M	-6.47M	-8.46M	-8.34M	-11.2M	-8.9M	-11.61M	-14.28M	-17.79M	-20.19M	-23.76M
Debt / Equity	-	-	-	-	-	-	-	-	-	-	-	0.00x	0.01x	0.01x	0.02x	0.02x	0.01x	0.01x	0.01x	0.01x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-714.20x	-252.10x	-1320.00x	-3450.00x
Total Equity	8.62M	12.6M	16.46M	20.15M	9.84M	10.1M	12.17M	4.72M	4.95M	3.77M	5.6M	7.73M	7.21M	9.9M	7.31M	10.84M	13.53M	17M	19.45M	21.93M
Equity Growth %	-12.39%	24.83%	35.27%	326.57%	98.93%	167.56%	117.17%	-38.9%	-31.43%	-61.9%	-23.35%	-28.69%	-46.68%	-41.75%	-62.41%	-50.57%	-46.42%	-41.05%	-38.05%	68.49%
Book Value per Share	0.74	1.08	1.42	1.73	1.80	2.11	2.83	6.00	5.00	7.40	11.02	18.58	26.63	51.62	57.66	85.74	107.03	134.58	155.03	175.18
Total Shareholders' Equity	8.62M	12.6M	16.46M	20.15M	9.84M	10.1M	12.17M	4.72M	4.95M	3.77M	5.6M	7.73M	7.21M	9.9M	7.31M	10.84M	13.53M	17M	19.45M	21.93M
Common Stock	1K	1K	1K	1K	1K	0	0	0	0	0	0	0	0	0	0	0	1K	1K	1K	0
Retained Earnings	-167.35M	-163.19M	-159.06M	-155.05M	-152.68M	-150.29M	-148.13M	-146.36M	-144.73M	-143.21M	-141.36M	-139.21M	-137.31M	-134.53M	-131.98M	-128.38M	-125.65M	-122.07M	-119.54M	-116.9M
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0